2nd Quarter - Report

BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC for BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC

Firm
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

HR 1629, S250 Fairness in Orphan Drug Exclusivity Act; Administration of controlled substances by HCPs; Storage of controlled substances

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS)

Bills named: H.R. 1629 (117th)

Alcohol and Drug Abuse ALC

HR 1629, S250 Fairness in Orphan Drug Exclusivity Act; Administration of controlled substances by HCPs; Storage of controlled substances

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1629 (117th)

Pharmacy PHA

HR 1629, S250 Fairness in Orphan Drug Exclusivity Act; Administration of controlled substances by HCPs; Storage of controlled substances

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 1629 (117th)

Insurance INS

HR 1629, S250 Fairness in Orphan Drug Exclusivity Act; Administration of controlled substances by HCPs; Storage of controlled substances

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1629 (117th)

Health Issues HCR

HR 1629, S250 Fairness in Orphan Drug Exclusivity Act; Administration of controlled substances by HCPs; Storage of controlled substances

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: SENATE; Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1629 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.